The atrial septal defect occluder system (ASDOS) (Osypka Corp., Grenzach-Wyhlen, Germany) has been used clinically for transcatheter closure of secundum atrial septal defect (ASD) and patent foramen ovale (PFO) after episodes of cerebral embolism over the last 10 years. In this article, the up-to-date experience with this system is reviewed.